[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Milestone Scientific (MLSS)

Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,562
  • Shares Outstanding, K 88,075
  • Annual Sales, $ 8,970 K
  • Annual Income, $ -5,720 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.97
  • Price/Sales 3.19
  • Price/Cash Flow N/A
  • Price/Book 11.44
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $-0.01 on 05/13/26
  • Next Earnings Date 08/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Dental Suppliers

Options Overview Details

View History
  • Implied Volatility 0.00% (-315.80%)
  • Historical Volatility 108.76%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 852.73% on 03/26/26
  • IV Low 0.00% on 05/18/26
  • Expected Move (DTE 29) 0.0850 (21.30%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 104
  • Open Int (30-Day) 114
  • Expected Range 0.3140 to 0.4840

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.01
  • Growth Rate Est. (year over year) +9,990,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2834 +40.79%
on 04/21/26
0.4826 -17.32%
on 05/07/26
+0.1090 (+37.59%)
since 04/20/26
3-Month
0.2400 +66.25%
on 03/03/26
0.4826 -17.32%
on 05/07/26
+0.1414 (+54.89%)
since 02/20/26
52-Week
0.2181 +82.94%
on 01/22/26
1.0300 -61.26%
on 05/21/25
-0.6510 (-62.00%)
since 05/20/25

Most Recent Stories

More News
Milestone Scientific Reports Financial Results for First Quarter 2026

Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Inc. Completes $2.15 Million Private Placement

ROSELAND, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry

ROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025

ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.3990 (+14.99%)
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS),  a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...

MLSS : 0.3990 (+14.99%)

Business Summary

Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling...

See More

Key Turning Points

3rd Resistance Point 0.4961
2nd Resistance Point 0.4531
1st Resistance Point 0.4260
Last Price 0.3990
1st Support Level 0.3559
2nd Support Level 0.3129
3rd Support Level 0.2858

See More

52-Week High 1.0300
Fibonacci 61.8% 0.7199
Fibonacci 50% 0.6240
Fibonacci 38.2% 0.5282
Last Price 0.3990
52-Week Low 0.2181

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.